Navigation Links
Survival Data Available From Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer

Myers Squibb's Pharmaceutical Research Institute are studying ways to improve current cancer treatments and identify better, more effective medicines for the future.

Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995 regarding product development. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including risk factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Bristol-Myers Squibb's business, particularly those identified in the cautionary factors discussion in the Bristol-Myers Squibb's Annual Report on Form 10-K for the year ended December 31, 2006 and in our Quarterly Reports on Form 10-Q. Bristol-Myers Squibb undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

CONTACT: Media, Rebecca Gregory, Corporate Communications for ImCloneSystems Incorporated, +1-646-638-5058, or ; or MadelineMalia, +1-609-252-3347, or , or Tony Plohoros,+1-609-252-7938, or , or Investors, John Elicker,+1-212-546-3775, or , all of Bristol-Myers Squibb media@imclone.com Madeline.Malia@bms.com tony.plohoros@bms.com John.Elicker@bms.com

Ticker Symbol: (NYSE:BMY),(NASDAQ-NMS:IMCL)


'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
5. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
6. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
7. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
8. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
9. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
10. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
11. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
Post Your Comments:
(Date:12/15/2009)... -- Cumberland Pharmaceuticals Inc. ( CPIX) ... results for a patient preference study evaluating Kristalose ... laxative packaged as a crystalline powder, compared to ... the only prescription-strength laxative available in pre-measured powder ... a recent diagnosis of chronic constipation were administered ...
(Date:12/15/2009)... Pa., Dec. 15 Certified healthcare providers ... of complications from the H1N1 flu virus may ... it, the Department of Health announced today. ... to everyone because approximately 3.2 million doses of ... administered it to individuals in the priority groups. ...
(Date:12/15/2009)... ZURICH, Ill., Dec. 15 Fenwal Inc., ... blood collection, separation, safety and availability, announced today ... granted Fenwal approval to market InterSol ® ... ® solution is a specialized product used ... platelets, a vital blood component used to prevent ...
Breaking Medicine Technology:Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 3Department of Health Urges Expanded H1N1 Vaccination Efforts to Include All Patients 2Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets 2Westaim announces 2009 third quarter results 61351 1Westaim announces 2009 third quarter results 61351 2Westaim announces 2009 third quarter results 61351 3Westaim announces 2009 third quarter results 61351 4Physicians Heal Bridge to Nowhere 3B Iraqi Girl With Rare Neuromuscular Disorder Has New Hope 61349 1Physicians Heal Bridge to Nowhere 3B Iraqi Girl With Rare Neuromuscular Disorder Has New Hope 61349 2Physicians Heal Bridge to Nowhere 3B Iraqi Girl With Rare Neuromuscular Disorder Has New Hope 61349 3Physicians Heal Bridge to Nowhere 3B Iraqi Girl With Rare Neuromuscular Disorder Has New Hope 61349 4Physicians Heal Bridge to Nowhere 3B Iraqi Girl With Rare Neuromuscular Disorder Has New Hope 61349 5Governor Rendell Helps to Break Ground for New Childrens Hospital at Penn State Hershey 61347 1Governor Rendell Helps to Break Ground for New Childrens Hospital at Penn State Hershey 61347 2
(Date:12/15/2009)... -- Palo Alto Networks(TM), the network security company, ... PA-4000 Series next-generation firewalls for accurate threat prevention ... and control over applications such as peer-to-peer file ... university with eight facilities on five campuses. The ... number of academic schools and institutions throughout Japan. ...
(Date:12/15/2009)... where all couples of reproductive age were evaluated, Italian ... The number of children born with cystic fibrosis decreases ... mutation carriers increases, a new study finds. , CF ... northeast Italy for many years. Since the 1990s, the ... number of infants born with CF. , Two different ...
(Date:12/15/2009)... promised but not delivered ,, WASHINGTON, Dec. ... Congress to ensure that healthcare reform does not ... of insurance companies in 37 states. ,, Prostate ... of the population and individuals who are identifiable ... men who have a family history of prostate ...
(Date:12/15/2009)... Patient advocate Betsy ... of Congress that, "it doesn,t matter whether there,s a ... without a public option - give government authority over ... fund a new social agenda by shifting billions of ... newly arriving immigrants, and local politicians." ,, ...
(Date:12/15/2009)... Physical activity is known to reduce depression and ... study indicates that this effect stems from an individual,s ... or her ability to achieve certain physical goals. ... Medicine . , "We base our arguments on fatigue ... professor of kinesiology and community health at the University ...
Breaking Medicine News(10 mins):Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2Health News:Mastery of physical goals lessens disease-related depression and fatigue 2
... money totaling $30,000,has been announced for the inaugural Mississippi Blues Marathon and,Half-Marathon, scheduled for January 5, 2008. Prize money ... Male Female 1st Place ... 3,000 3rd Place 2,000 ... 1,500 5th Place 1,000 1,000, Wheelchair ...
... LOUIS, Oct. 29 Solae, LLC, today announced that,global ... increase by 12,to 24 percent, depending on the product ... Solae CEO and Chairman Craig Binetti said, "Market ... Fortunately, we,re in a great,position to help our customers ...
... Calif., Oct. 29 Howard A.,McLure, President of ... elected Chairman of the Pharmaceutical Care Management Association,s,(PCMA) ... addition to,becoming the new Board Chairman, Mr. McLure ... a two-day event which features health care leaders,discussing ...
... a two-day symposium Nov. 1-2 on diseases of the aorta, ... died of an aortic dissection four years ago. , The ... held in Mary S. Harkness Auditorium at 333 Cedar Street. ... chief of cardiothoracic surgery at Yale. The summit is open ...
... on the topics of cardiovascular risk in chronic ... and ethnic disparities of kidney disease, and anemia ... the American Society of Nephrology,s 40th Annual Meeting ... policy-centered news briefing on Saturday, November 3. , ...
... it can prevent or shorten the illness , MONDAY, Oct. ... blood may help prevent pneumonia in elderly nursing home residents, ... University looked at 617 people 65 and older in 33 ... those with normal blood zinc concentrations were about 50 percent ...
Other Medicine News:Health News:Solae Announces Global Price Increase for Soy Protein Ingredients 2Health News:CVS Caremark's Howard McLure Elected New PCMA Board Chairman 2Health News:Zinc Helps Elderly Ward Off Pneumonia 2
The Bledsoe Ultimate CI is a sport functional knee brace designed for instabilities of combined ACL and PCL injured knees. Additional knee injuries to the medial collateral ligament along with the cr...
... The Bledsoe Cage is ... designed for instabilities of combined ... Additional knee injuries to the ... the crutiate ligaments can be ...
... post-op care demands the best, the Bledsoe Extender ... to 34" (56 cm to 86 cm) in ... leg circumference, this brace easily fits patients from ... tall, and adapts as the patient progresses. The ...
... The Bledsoe Lever Lock Knee ... quick extension lock of the arthroscopic ... to allow motion for rehabilitation or ... quickly locked "rigidly" in full extension ...
Medicine Products: